If there’s an obvious problem or issue that no one is willing to acknowledge or discuss—especially although doing so would likely solve all other smaller or less serious issues—then there is a ...

More than 900 contestants vying for the $10,000 grand prize scoured South Florida for 10 days during the 2026 Florida Python Challenge.

Forecasts of explosive AI progress predict that what researchers call recursive self-improvement is on the horizon.  But a new study suggests that it might take a while for us to get there. The ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

This transcript was created using speech recognition software. While it has been reviewed by human transcribers, it may contain errors. Please review the episode audio before quoting from this ...

Face ID and fingerprints are convenient, but law enforcement can bypass them much more easily than a passcode. Here's why you should go back to basics to improve your privacy and security. I review ...

Discover the best open-source vulnerability scanners of 2026 that help CIOs minimize security costs while ensuring robust protection against software vulnerabilities. Learn about their features and ...

We independently review everything we recommend. We may make money from the links on our site. Learn more› By Katie Okamoto Katie Okamoto is an editor focusing on sustainability. She’s covered the ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Worries about AI one day replacing human workers have intensified recently — and as it turns out, that ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...